The DOI matches its Crossref record; 41 of the 45 references it cites were found in a registry or an index.
Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone
Abstract
IL-6 has emerged as an important cytokine upregulated in states of insulin resistance such as type 2 diabetes. We evaluated the chronic effect of IL-6 on insulin signaling in 3T3-F442A and 3T3-L1 adipocytes. First, cells responded to a chronic treatment with IL-6 by initiating an autoactivation process that increased IL-6 secretion. Second, IL-6-treated adipocytes showed a decreased protein expression of IR-beta subunit and IRS-1 but also an inhibition of the insulin-induced activation of IR-beta, Akt/PKB, and ERK1/2. Moreover, IL-6 suppressed the insulin-induced lipogenesis and glucose transport consistent with a diminished expression of GLUT4. IL-6-treated adipocytes failed to maintain their adipocyte phenotype as shown by the downregulation of the adipogenic markers FAS, GAPDH, aP2, PPAR-gamma, and C/EBP-alpha. IL-6 also induced the expression of SOCS-3, a potential inhibitor of insulin signaling. Finally, the effects of IL-6 could be prevented by rosiglitazone, an insulin-sensitizing agent. Thus, IL-6 may play an important role in the set-up of insulin resistance in adipose cell.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Gene expression studies with human adipose tissue have demonstrated that the levels of expression of MCP-1, colony-stimulating factor-3 and the urokinase plasminogen activator CD87 increase significantly in the adipose tissue of subjects with morbid obesity (31) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [31]
In the citing paper
“In obese subjects, these macrophages typically aggregate in crowns around apoptotic adipocytes (31) (Figs. 1 and 2).”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [31]
In the citing paper
“Hypoxia-inducible factor-1a, a transcription factor normally induced by hypoxia, is overexpressed in the subcutaneous adipose tissue of obese subjects and its expression is decreased during weight reduction (31) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [31]
In the citing paper
“In this study, the protein expression of IL-10 increased, suggesting a possible M1 to M2 (pro-inflammatory to anti-inflammatory) switch of macrophage phenotypes (31) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [31]
In the citing paper
“On the other hand, it seems likely that reduced secretion of pro-inflammatory mediators from adipocytes or activated macrophages of adipose tissue contributes to the effect of weight loss (31,36,65,67,142) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [31]
In the citing paper
“The parallelism between the down-regulation of these genes and the reduction in adiposity and adipocyte diameter by n-3 PUFA treatment suggests a positive relationship between adipose cell size and adipose tissue inflammation, agreeing with other observations (31,66) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [31]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-α,in Vivo1
Mohamed‐Ali, V., Goodrick, S., Rawesh, A., Katz, D. R., Miles, J. M., Yudkin, J. S., Klein, S., & Coppack, S. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4450 · Cited by 2,032
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Fried, S. K., Bunkin, D. A., & Greenberg, A. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4660 · Cited by 1,756
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Spiegelman, B. M. (1998) · Diabetes · doi:10.2337/diabetes.47.4.507 · Cited by 1,730
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T., & Kishimoto, T. (1989) · Cell · doi:10.1016/0092-8674(89)90438-8 · Cited by 1,396
Flagged first, then by citations
4 of the 45 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 383
High pulse pressure is related to risk of type 2 diabetes mellitus in Chinese middle-aged females
Zhang, L., Wang, B., Wang, C., Li, L., Ren, Y., Zhang, H., Yang, X., Zhao, Y., Han, C., Zhou, J., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.233 · Cited by 26
Miranville, A., Herling, A. W., Biemer‐Daub, G., & Voss, M. D. (2010) · Obesity · doi:10.1038/oby.2010.81 · Cited by 26
Superantigen activates the gp130 receptor on adipocytes resulting in altered adipocyte metabolism
Banke, E., Rödström, K. E. J., Ekelund, M., Dalla‐Riva, J., Lagerstedt, J. O., Nilsson, S., Degerman, E., Lindkvist‐Petersson, K., & Nilson, B. (2014) · Metabolism · doi:10.1016/j.metabol.2014.03.004 · Cited by 26
Sterculic Oil, a Natural SCD1 Inhibitor, Improves Glucose Tolerance in Obese ob/ob Mice
Ortinau, L. C., Pickering, R. T., Nickelson, K. J., Stromsdorfer, K. L., Naik, C., Haynes, R. A., Bauman, D. E., Rector, R. S., Fritsche, K. L., & Perfield, J. W. (2012) · ISRN Endocrinology · doi:10.5402/2012/947323 · Cited by 27
Peeraully, R., Sievert, H., Bulló, M., Wang, B., & Trayhurn, P. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0118-x · Cited by 25
Lakhdar, N., Denguezli, M., Zaouali, M., Zbidi, A., Tabka, Z., & Bouassida, A. (2013) · Inflammation · doi:10.1007/s10753-013-9661-8 · Cited by 25
A Potential Role for Pro-Inflammatory Cytokines in the Development of Insulin Resistance in Horses
Suagee, J. K., Corl, B. A., & Geor, R. J. (2012) · Animals · doi:10.3390/ani2020243 · Cited by 25
Obésité, inflammation et insulinorésistance : quel rôle pour les adipokines ?
Antuna-Puente, B. P., Fève, B., Fellahi, S., & Bastard, J. (2007) · Therapies · doi:10.2515/therapie:2007055 · Cited by 25
Self-citationPoletto, A. C., David-Silva, A., Yamamoto, A. P. D. M., Machado, U. F., & Furuya, D. T. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0015-6 · Cited by 25
Kusuyama, J., Bandow, K., Ohnishi, T., Amir, M. S., Shima, K., Semba, I., & Matsuguchi, T. (2019) · Biochemical Journal · doi:10.1042/bcj20190709 · Cited by 25
SOCS and diabetes—ups and downs of a turbulent relationship
Suchy, D., Łabuzek, K., Machnik, G., Kozłowski, M., & Okopień, B. (2013) · Cell Biochemistry and Function · doi:10.1002/cbf.2940 · Cited by 27
Les relations entre obésité, inflammation et insulinorésistance : acquisitions récentes
Fève, B., Bastard, J., & Vidal, H. (2006) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2006.03.020 · Cited by 33
Self-citation[Studies on the active constituents of Momordica charantia L].
Zhu, Z. J., Zhong, Z. C., Luo, Z. Y., & Xiao, Z. Y. (1990) · PubMed · Cited by 25
Li, Z., Shen, G., Shi, M., Zheng, Y., Guan, Y., Xin, Y., Wang, M., Zhao, F., Ren, D., & Zhao, J. (2023) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2023.03.002 · Cited by 26
Yang, Y., Fu, H., Zhang, B., & Wu, Y.-B. (2022) · Inflammation · doi:10.1007/s10753-022-01711-3 · Cited by 24
Kumar, H., Mishra, M., Bajpai, S., Pokhria, D., Arya, A. K., Singh, R. K., & Tripathi, K. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0307-8 · Cited by 24
The Role of Inflammatory Pathway Genetic Variation on Maternal Metabolic Phenotypes during Pregnancy
Urbanek, M., Hayes, M. G., Lee, H., Freathy, R. M., Lowe, L. P., Ackerman, C. M., Jafari, N., Dyer, A. R., Cox, N. J., Dunger, D. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032958 · Cited by 25
Zini, E., Linscheid, P., Franchini, M., Kaufmann, K., Monnais, E., Kutter, A. P. N., Ackermann, M., Lutz, T. A., & Reusch, C. E. (2007) · The Veterinary Journal · doi:10.1016/j.tvjl.2007.10.022 · Cited by 24
Wang, C., & Tsai, H. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i3.238 · Cited by 25
Tzeng, T. F., Liu, I.-M., & Cheng, J. (2005) · Diabetologia · doi:10.1007/s00125-005-1791-6 · Cited by 23
Daidzein improves insulin resistance in ovariectomized rats
Cao, Y., Zhang, S. F., Zou, S., & Xia, X. (2012) · Climacteric · doi:10.3109/13697137.2012.664831 · Cited by 22
Castellani, L. N., Perry, C. G. R., MacPherson, R. E. K., Root-McCaig, J., Huber, J. S., Arkell, A. M., Simpson, J. A., & Wright, D. C. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00551.2015 · Cited by 22
Moradi, S., Mirzaei, K., Abdurahman, A. A., & Keshavarz, S. A. (2017) · Osteoporosis International · doi:10.1007/s00198-017-3914-6 · Cited by 22
Liver Injury and Acute Liver Failure After Bariatric Surgery
Moolenaar, L. R., de Waard, N. E., Heger, M., de Haan, L. R., Slootmaekers, C. P. J., Nijboer, W. N., Tushuizen, M. E., & van Golen, R. F. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001662 · Cited by 22
The complex effects of adipokines in the patients with kidney disease
Vahdat, S. (2018) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_1115_17 · Cited by 21
Kuhn, E., Bourgeois, C., Keo, V., Viengchareun, S., Muscat, A., Méduri, G., Menuet, D. L., Fève, B., & Lombès, M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00323.2013 · Cited by 23
Bogazzi, F., Raggi, F., Russo, D., Bohlooly‐Y, M., Sardella, C., Urbani, C., Lombardi, M., Manetti, L., Lupi, I., Törnell, J., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1220 · Cited by 20
Reynolds, K., & Goldberg, R. B. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605010-00004 · Cited by 20
Ogasawara, J., Kitadate, K., Nishioka, H., Fujii, H., Sakurai, T., Kizaki, T., Izawa, T., Ishida, H., Tanno, M., & Ohno, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.082 · Cited by 19
Adipokines and the signaling role of adipose tissue in inflammation and obesity
Wood, I. S., & Trayhurn, P. (2006) · Future Lipidology · doi:10.2217/17460875.1.1.81 · Cited by 18
Insulin use in chronic kidney disease and the risk of hypoglycemic events
Grube, D., Wei, G., Boucher, R. E., Abraham, N., Zhou, N., Gonce, V., Carle, J., Simmons, D. L., & Beddhu, S. (2022) · BMC Nephrology · doi:10.1186/s12882-022-02687-w · Cited by 19
Rengachar, P., Polavarapu, S., & Das, U. N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1053879 · Cited by 17
Kozono, M., Uto, H., Ibusuki, R., Arima, S., Oda, K., Taguchi, H., Sasaki, F., Nasu, Y., Hashimoto, S., Setoyama, H., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5875 · Cited by 17
Chen, L., Lin, X., Xu, X., Wang, L., Teng, H., & Cao, H. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110953 · Cited by 17
Guerre-Millo, M. (2006) · Journal de la Société de Biologie · doi:10.1051/jbio:2006005 · Cited by 16
Thompson, A. C. S., Nuñez, M., Davidson, R. D., Horm, T. M., Schnittker, K., Hart, M. V., Suarez, A. M., & Tsao, T. (2012) · Journal of Lipid Research · doi:10.1194/jlr.d031286 · Cited by 16
Ahmed, K., Jeong, M. H., Chakraborty, R., Cho, K. H., Sim, D. S., Hong, Y. J., Ahn, Y., Hachinohe, D., Cho, M., Kim, C. J., et al. (2012) · Korean Circulation Journal · doi:10.4070/kcj.2012.42.3.164 · Cited by 16
Basu, S., Zethelius, B., Helmersson, J., Berne, C., Larsson, A. O., & Ärnlöv, J. (2011) · PubMed Central · Cited by 16
Wróblewski, A. M., Strycharz, J., Świderska, E., Balcerczyk, A., Szemraj, J., Drzewoski, J., & Śliwińska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136964 · Cited by 15
Predictors of the early impairment of renal disease in human obesity
Gilardini, L., Zulian, A., Girola, A., Redaelli, G., Conti, A., & Invitti, C. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.227 · Cited by 15
Belle, T. L. V., Pagni, P. P., Liao, J., Sachithanantham, S., Dave, A., Hani, A. B., Manenkova, Y., Amirian, N., Yang, C., Morin, B., et al. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.02.002 · Cited by 14
Gesing, A., Masternak, M. M., Lewiñski, A., Karbownik‐Lewińska, M., Kopchick, J. J., & Bartke, A. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls231 · Cited by 14
Feng, X., Tang, S.-Y., Jiang, Y., & Zhao, W. (2017) · African Journal of Traditional Complementary and Alternative Medicines · doi:10.21010/ajtcam.v14i3.5 · Cited by 14
Rosiglitazone regulates IL-6-stimulated lipolysis in porcine adipocytes
Yang, Y., & Yang, G. (2010) · Biochemistry and Cell Biology · doi:10.1139/o10-116 · Cited by 13
Arsenic and diabetes mellitus: a putative role for the immune system
Liu, J., Hermon, T., Gao, X., Dixon, D., & Xiao, H. (2023) · All Life · doi:10.1080/26895293.2023.2167869 · Cited by 12
An improved in vitro 3T3-L1 adipocyte model of inflammation and insulin resistance
Odeniyi, I. A., Ahmed, B., Anbiah, B., Hester, G., Abraham, P., Lipke, E. A., & Greene, M. W. (2024) · Adipocyte · doi:10.1080/21623945.2024.2414919 · Cited by 13
Gu, J., Zhou, P., Liu, Y., Xu, Q., Chen, X., Chen, M., Chen, L., Qu, C., Tong, Y., Yu, Q., et al. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111776 · Cited by 13
Lim, J. Y., & Kim, E. (2023) · Metabolites · doi:10.3390/metabo13090979 · Cited by 13
The emerging role of the gut microbiome in polycystic ovary syndrome
He, Y., Jin, X., Wang, H., Dai, H., Lu, X., Zhao, J., Zhang, H., Chen, W., & Wang, G. (2021) · F&S Reviews · doi:10.1016/j.xfnr.2021.03.003 · Cited by 14
Biazi, G. R., Frasson‐Uemura, I. G., Miksza, D. R., Ferraz, L. S., Diaz, B. F., Bertolini, G. L., & de Souza, H. M. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3817 · Cited by 13
Regulation of Appetite and Insulin Signaling in Inflammatory States
TELI, T., XANTHAKI, D., & Karalis, K. P. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.022 · Cited by 12
Myokines: Do they really exist?
Manabe, Y., Miyatake, S., & Takagi, M. (2012) · The Journal of Physical Fitness and Sports Medicine · doi:10.7600/jpfsm.1.51 · Cited by 11
Is the canine corpus luteum an insulin-sensitive tissue?
Sousa, L. M. M. D. C., Silva, R. D. S., da Fonseca, V. U., Leandro, R. M., Vincenzo, T. S., Alves-Wagner, A. B., Machado, U. F., & Papa, P. D. C. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0173 · Cited by 11
Inflammatory Response, a Key Pathophysiological Mechanism of Obesity-Induced Depression
Shao, S., Liu, D.-Q., Zhang, B., & Huang, S.-M. (2020) · Mediators of Inflammation · doi:10.1155/2020/8893892 · Cited by 12
Interleukins in adipose tissue: Keeping the balance
Antuna-Puente, B., Fellahi, S., McAvoy, C., Fève, B., & Bastard, J. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111531 · Cited by 11
Self-citationBéréziat, V., Moritz, S., Klonjkowski, B., Decaudain, A., Auclair, M., Éloit, M., Capeau, J., & Vigouroux, C. (2005) · Biochimie · doi:10.1016/j.biochi.2005.05.010 · Cited by 10
Self-citationWan, Z., Mah, D., Simtchouk, S., Kluftinger, A., & Little, J. P. (2014) · Adipocyte · doi:10.4161/21623945.2014.985020 · Cited by 9
Prednisolone induces the Wnt signalling pathway in 3T3-L1 adipocytes
Fleuren, W., Linssen, M. M. L., Toonen, E. J. M., van der Zon, G. C. M., Guigas, B., de Vlieg, J., Dokter, W. H. A., Ouwens, D. M., & Alkema, W. B. L. (2013) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2013.774022 · Cited by 9
Ugochukwu, N. H., & Figgers, C. L. (2006) · Nutrition Research · doi:10.1016/j.nutres.2006.05.003 · Cited by 8
Kralisch, S., Klein, J. C., Lössner, U., Blüher, M., Paschke, R., Stümvoll, M., & Faßhauer, M. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.04.027 · Cited by 8
Gesing, A., Masternak, M. M., Wang, F., Karbownik‐Lewińska, M., & Bartke, A. (2011) · AGE · doi:10.1007/s11357-011-9232-6 · Cited by 7
Selenscig, D. A., Ferreira, M. D. R., Chicco, A. G., & Lombardo, Y. B. (2018) · Food & Function · doi:10.1039/c7fo01993a · Cited by 7
Lee, P. Y., Bazar, K. A., & Yun, A. J. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.02.036 · Cited by 7
Hariya, N., Mochizuki, K., Inoue, S., Morioka, K., Shimada, M., Okuda, T., & Goda, T. (2014) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.60.52 · Cited by 6
Non-Alcoholic Fatty Steatohepatitis an Inflammatory Disorder Beyond the Liver
Cerpa‐Cruz, S. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000159 · Cited by 6
Norazmi, M. N., Mohamed, R., Nurul, A. A., & Yaacob, N. S. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/849195 · Cited by 6
Burini, R. C., Torezan, G. A., Portero, K. C. D. C., & McLellan, K. C. P. (2013) · Acervo Digital da Universidade Estadual Paulista (Universidade Estadual Paulista) · Cited by 6
Cazzola, M., Hanania, N. A., Page, C. P., Calzetta, L., Matera, M. G., & Rogliani, P. (2025) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2025.2514607 · Cited by 5
Orabi, M., Yeganeh, M. S., Chun, T., & Lo, J. F. (2025) · Small · doi:10.1002/smll.202504686 · Cited by 4
Dolutegravir-associated hyperglycemia: a narrative review
Buzibye, A., Castelnuovo, B., Bollinger, R. C., Ssebulime, J., Omali, D., Muller, D., Mulindwa, F., Laker, E. A. O., Waitt, C. J., Andia, I., et al. (2025) · AIDS Research and Therapy · doi:10.1186/s12981-025-00800-1 · Cited by 5
Chen, X., Zhang, H., Fang, Z., Wang, D., Song, Y., Zhang, Q., Hou, J., Yang, S., Xu, D., Fei, Y., et al. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03433-y · Cited by 5
Gesing, A., Bartke, A., Wang, F., Karbownik‐Lewińska, M., & Masternak, M. M. (2011) · Biological Chemistry · doi:10.1515/bc.2011.051 · Cited by 5
Thiazolidinediones and vascular damage
Goldberg, R. B. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328054c655 · Cited by 5
Combined effect of C-reactive protein and stavudine on adipogenesis
Stankov, M. V., Schmidt, R. E., & Behrens, G. M. N. (2008) · Antiviral Therapy · doi:10.3851/imp1296 · Cited by 5
Hu, Y., & Yang, S. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-03817-y · Cited by 4
Li, J., CHEN, T., Li, K., Yan, H.-T., Li, X., Yang, Y. C., Zhang, Y., Su, B., & Li, F. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3087 · Cited by 4
Binette, A., Blouin, S., Ardilouze, A., & Pasquier, J. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1223031 · Cited by 4
Wang, Y., Chen, G., Xu, M., Cui, Y., He, W., Zeng, H., Zeng, T., Cheng, R., & Li, X. (2024) · Biomolecules · doi:10.3390/biom14040501 · Cited by 6
Schleh, M. W., Ryan, B. J., Ahn, C., Ludzki, A. C., Pelt, D. W. V., Pitchford, L. M., Chugh, O. K., Luker, A. T., Luker, K. E., Samovski, D., et al. (2024) · Acta Physiologica · doi:10.1111/apha.14249 · Cited by 5
IL-4 and IL-6 levels and adipose tissue distribution in HIV-1 patients under antiretroviral therapy
Belo, S., Santos, A. C., Madureira, A. J., Pereira, J., Sarmento, A., Carvalho, D. M., & Freitas, P. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0256-0 · Cited by 4
Murayama, Y., Mochizuki, K., Shimada, M., Fujimoto, S., Nukui, K., Shibata, K., & Goda, T. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf901484t · Cited by 4
Ouellet, J., Berthiaume, M., Corriveau, S., Rola‐Pleszczynski, M., & Pasquier, J. (2013) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12089 · Cited by 4
Bi, X., Tan, H., Xing, S. S., Zhong, M., Zhang, Y., & Zhang, W. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345716 · Cited by 4
Ramsay, T. G., Blomberg, L. A., & Caperna, T. J. (2013) · animal · doi:10.1017/s1751731113001250 · Cited by 4
Lakhdar, N., Denguezli, M., Zaouali, M., Zbidi, A., Tabka, Z., & Bouassida, A. (2015) · Pediatric Rheumatology · doi:10.1186/1546-0096-13-s1-p194 · Cited by 4
The Relationship Among Obesity, Inflammation, and Insulin Resistance
Bastard, J., & Fève, B. (2013) · Wiley eBooks · doi:10.1002/9781118395318.ch17 · Cited by 4
Self-citationShimamura, Y., Noaki, R., Oura, Y., Ichikawa, K., Kan, T., & Masuda, S. (2023) · Microorganisms · doi:10.3390/microorganisms11041039 · Cited by 3
Wang, F., Tian, Y., Li, G., Chen, X., Yuan, H. Y., Wang, D., Li, J., Shen, J., Tao, Z., Fu, Y., et al. (2012) · British Poultry Science · doi:10.1080/00071668.2012.746639 · Cited by 3
Kinase-dependent pathways and the development of insulin resistance in hepatocytes
Rondinone, C. M. (2007) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2.2.195 · Cited by 4
Gawryjołek, M., Wiciński, M., Zabrzyńska, M., Ohla, J., & Zabrzyński, J. (2024) · Nutrients · doi:10.3390/nu16213735 · Cited by 2
Multidimensional risk impact of obesity on breast cancer incidence, treatment, and prognosis
Liu, Y., Xu, S., Yang, H., & Wang, Y. (2026) · International Journal of Obesity · doi:10.1038/s41366-025-02008-9 · Cited by 2
Dinatale, B., González, F. B., Bottasso, O., & Pérez, A. R. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102028 · Cited by 2
Çelik, S. P., Parıltı, D. N., Açık, L., Yalçın, M. M., Yetkin, İ., & Yunusov, E. (2024) · TURKISH JOURNAL OF BIOLOGY · doi:10.55730/1300-0152.2688 · Cited by 3
Obesity, Type 2 Diabetes and Cancer
Ferguson, R. D., & LeRoith, D. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0598-6_3 · Cited by 2
Bouzid, T., Hamel, F. G., & Lim, J. Y. (2016) · Cited by 2
Ibrahim, Y. F., Toni, N. D. M., Thabet, K., Hegazy, A., & Bahaa, H. A. (2020) · Minia Journal of Medical Research · doi:10.21608/mjmr.2022.221583 · Cited by 2
Cytokines associated with insulin resistance in critically ill patients
Omar, S., Wilgen, U., & Crowther, N. J. (2007) · Critical Care · doi:10.1186/cc5280 · Cited by 2
Doramectin attenuates inflammation, obesity and insulin resistance in food-borne obese mice
Jin, T., Jia, J., Li, W., Wu, P., Liu, T., Luo, B., & Zhang, Z. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150404 · Cited by 1
Yaribeygi, H., Mirmohammadkhani, M., Rashidy‐Pour, A., Sathyapalan, T., Foroutan, M., Najmaldin, A., Hemmati, M. A., & Memaripanah, N. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2539252 · Cited by 1
MASLD and sarcopenia research (2012–2025): a multi-database bibliometric analysis
Gao, K., Xun, L., Hao, S., An, M., Zuo, L., Wang, J., Wang, Y., & He, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1834112 · Cited by 1
Metadata
- Authors
- Lagathu, C., Bastard, J.-P., Auclair, M., Maachi, M., Capeau, J., & Caron, M.
- Affiliations
- Inserm (FR)
- Corresponding author
- Caron, Martine
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 311
- Issue
- 2
- Pages
- 372-379
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W2061613314
- Cited by
- 385
- References
- 45
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 15 · 2023: 11 · 2022: 15 · 2021: 9 · 2020: 12 · 2019: 6 · 2018: 13 · 2017: 17 · 2016: 16 · 2015: 12 · 2014: 17 · 2013: 25 · 2012: 29
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Biochemical and Biophysical Research Communications (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- interleukin-6, insulin resistance, adipocytes, rosiglitazone, insulin signaling, insulin receptor beta, IRS-1, Akt, ERK1/2, GLUT4, lipogenesis, adipogenesis, SOCS3, type 2 diabetes, 3T3-L1 cells
- MeSH terms
- Suppressor of Cytokine Signaling 3 Protein, Rosiglitazone, Animals, Dose-Response Relationship, Drug, Glucose, Insulin Resistance, Proteins, Repressor Proteins, Transcription Factors, Signal Transduction, Interleukin-6, Up-Regulation, 3T3 Cells, Adipocytes, 3T3-L1 Cells, Thiazolidinediones, Suppressor of Cytokine Signaling Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review